Open-Label Treatment Extension of Protocol MNTX 301

NCT01367600 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Terminal Illness

Interventions

DRUG: SC Methylnaltrexone (MNTX)

Sponsor

Bausch Health Americas, Inc.